Current Report Filing (8-k)
February 18 2020 - 6:29AM
Edgar (US Regulatory)
0001109354
false
0001109354
2020-02-17
2020-02-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 18, 2020
BRUKER CORPORATION
(Exact name of registrant as
specified in its charter)
Delaware
|
|
000-30833
|
|
04-3110160
|
(State
or other jurisdiction of
|
|
Commission
File No.
|
|
(I.R.S.
Employer
|
Incorporation or
organization)
|
|
|
|
Identification
No.)
|
40
Manning Road
Billerica,
MA 01821
(Address
of principal executive offices) (Zip Code)
(978) 663-3660
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following
provisions:
¨
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of
the Act:
Title of Each Class
|
|
Trading Symbol(s)
|
|
Name of Each Exchange on Which Registered
|
Common Stock, $0.01 par value per share
|
|
BRKR
|
|
The Nasdaq Global Select Market
|
Indicate by check mark whether the registrant is an
emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ¨
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 Results of Operations and Financial Condition.
On February 18, 2020,
Bruker Corporation (the “Company”) issued a press release reporting certain preliminary operating results for the fourth
quarter and year ended December 31, 2019, and announcing that the Company’s Audit Committee of the Board of Directors has
initiated an internal investigation into an allegation recently received in connection with the year-end close, primarily relating
to income tax matters including the effective income tax rate for 2019 and the related income tax balance sheet accounts. The Company
also announced that it will hold a conference call on February 18, 2020 to discuss these preliminary operating results. The Company’s
independent registered public accounting firm has not audited or performed any procedures with respect to the preliminary operating
results disclosed in the press release. The press release is furnished as Exhibit 99.1 to this Current Report.
Item 7.01 Regulation FD Disclosure.
The information set forth in Item 2.02 of this Current Report is incorporated into this
Item 7.01 by reference.
The information furnished in Item 2.02 and
Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities
Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Item 8.01 Other Events.
As announced in the
press release dated February 18, 2020, the Company’s Audit Committee of the Board of Directors has initiated an internal
investigation into an allegation recently received in connection with the year-end close, primarily relating to income tax matters
including the effective income tax rate for 2019 and the related income tax balance sheet accounts. The Audit Committee is overseeing
the investigation with the assistance of independent, experienced external advisors. The investigation is in its early stages and
the Company cannot predict its duration or outcome.
Item 9.01 Financial Statements and Exhibits.
Forward Looking Statements
Any statements contained in this Current
Report on Form 8-K that do not describe historical facts may constitute forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements
regarding our preliminary fiscal year 2019 performance and statements related to the internal investigation announced today. Any
forward-looking statements contained herein are based on current expectations, but are subject to risks and uncertainties that
could cause actual results to differ materially from those indicated, including, but not limited to, risks and uncertainties relating
to the preliminary nature of our fiscal year 2019 financial information, which is subject to completion of our year-end-audit,
the outcome of the internal investigation announced today, and other risk factors discussed from time to time in our filings with
the Securities and Exchange Commission, or SEC. These and other factors are identified and described in more detail in our filings
with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2018. We expressly
disclaim any intent or obligation to update these forward-looking statements other than as required by law.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BRUKER CORPORATION
(Registrant)
|
|
|
Date: February 18, 2020
|
By:
|
/s/GERALD N. HERMAN
|
|
|
Gerald N. Herman
|
|
|
Chief Financial Officer
|
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Apr 2023 to Apr 2024